Dr. Kate Connor is a Postdoctoral Researcher in the RCSI Laboratory for Tumour Biology and Molecular Imaging directed by Dr. Annette Byrne (Senior Lecturer), in the Department of Physiology and Medical Physics. Dr. Connor is funded under an SFI Technology Innovation Development Award (TIDA) with the goal of the project to develop a novel therapies for a form of incurable brain cancer (glioblastoma).
Part of the TIDA award requires researchers to participate in the SFI/EI ‘Get Started Technology Venture Programme’ held at the esteemed DCU Ryan Academy of Entrepreneurship. This program aims to highlight the feasibility of an innovative idea for further commercial exploitation and develops awareness of entrepreneurship and the commercialisation process for researchers in the early stages of the commercialisation pipeline.
The final day of the program took place on Nov 4th with researchers presenting their work to a panel of investors and judges with the aim of highlighting the significant scientific and commercial impact of their research. Winners of this ‘dragons den’ style event have also been given the opportunity to present their pitch at the SFI Summit meeting which took place on Nov 14th in Croke Park.
Dr. Connor was among 4 other successful candidates who were chosen to present their winning pitches at the Summit next week. This event was a wonderful opportunity to showcase the project and to potentially gain investment for future work towards translation of new therapies to brain cancer patients.
Dr. Connor successfully won the popular vote of which presentation deserved further investment.
Dr. Zaitun Zakaria on getting her PhD
and to Dr. Karen Coughlan and Dr. Shona Pfeiffer on obtaining their Diploma in Health Sciences Education
Dr. Sinead Kinsella and Prof. Jochen Prehn published a preview entitled ‘In the Middle of a Chain Interaction’ in the Journal of Molecular Cell-
see below for the link
Title: Advances in immunotherapy for the treatment of glioblastoma, please see link to journal below
Congratulations to Dr. Shona Pfeiffer for receiving IES Basic Science Grant ”research in microRNA therapeutics in the treatment of diabetes mellitus”.
To mark Cancer week (17th-23rd of October) , RCSI and the Centre for Systems Medicine are hosting a mini-symposium in the Cheyne Theatre, 123 St. Stephens Green @ 1pm-3 pm.
RCSI Principal Investigators will present an overview of their cancer research.
Dr. Robert O’ Connor from the Irish Cancer Society will also give a talk.
Everyone is invited to attend. Hope you can all make it. Please see Mini-Symposium Cancer week speakers
Dr. Manuela Salvucci and authors also published a paper in the Journal of ‘Clinical Cancer Research’. This study also investigated the potential clinical utility of a mathematical model (APOPTO-CELL) for identifying a patient-specific risk of unfavourable outcomes. see below for link
Congratulations to Dr. Andreas Linder and authors on their recent publication in the journal ‘Gut’. In this study they tested a system based biomarker and prognostic tool (DR-MOMP) for stage III colorectal cancer (CRC). They found that DR- MOMP could be potentially used as a prognostic tool to significantly improve established risk scores for patients with CRC.
See link here